Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia

Circulation

Volumn 89, Issue 5, 1994, Pages 2283-2289

  Van Wylen, David G L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

adenosine; ischemia; preconditioning

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; LACTIC ACID; PURINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENERGY CONSUMPTION; FEMALE; GLUCOSE METABOLISM; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; INTERSTITIAL FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; PURINE METABOLISM;

EID: 0028206853     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.5.2283     Document Type: Article

References (41)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990;82:609-619.
3. Miura T, Iimura O. Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc Res. 1993;27:36-42.
4. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res. 1993;27:542-550.
5. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66: 913-931.
6. Wolfe CL, Sievers RE, Visseren FLJ, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation. 1993;87:881-892.
7. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res. 1993;72:112-125.
8. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 1991;84:2495-2503.
9. Volovsek A, Subramanian R, Reboussin D. Effects of duration of ischemia during preconditioning on mechanical function, enzyme release and energy production in the isolated working rat heart. J Mol Cell Cardiol. 1992;24:1011-1019.
10. Van Wylen DGL, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM Jr. Cardiac microdialysis to measure interstitial adenosine and coronary blood flow. Am J Physiol. 1990;259:H1642-H1648.
11. Dorheim T, Wang T, Mentzer RM Jr, Van Wylen DGL. Interstitial purine metabolites during regional myocardial ischemia. J Surg Res. 1990;48:491-497.
12. Delyani JA, Van Wylen DGL. Endocardial and epicardial interstitial purine metabolites and lactate during graded ischemia. Am J Physiol. 1994;266:H1019-H1026.
13. 2 clearance measurements of blood flow: a review of technique and polarographic principles. Stroke. 1980;11:552-564.
14. Reimer KA, Murry CE, Jennings RB. Cardiac adaption to ischemia: ischemic preconditioning increases myocardial tolerance to subsequent ischemic episodes. Circulation. 1990;82:2266-2268.
15. Opie LH, Treasure T, Walker JM. The current status of stunning, hibernation, and preconditioning. Cardiovasc Res. 1993;27:886-890.
16. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res. 1993;27:3-8.
17. Mullane K. Myocardial preconditioning: part of the adenosine revival. Circulation. 1992;85:845-847.
18. Walker DM, Yellon DM. Ischaemic preconditioning: from mechanisms to exploitation. Cardiovasc Res. 1992;26:734-739.
19. Murray CE, Jennings RB, Reimer KA. New insights into potential mechanisms of ischemic preconditioning. Circulation. 1991;84: 442-445.
20. Nao BS, McClanahan TB, Groh MA, Schott RJ, Gallagher KP. The time limit of effective preconditioning in dogs. Circulation. 1990;83(suppl III):III-271. Abstract.
21. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol. 1986;251:H1306-H1315.
22. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation. 1993;87:208-215.
23. Nees S, Herzog V, Becker BF, Bock M, Des Rosiers CH, Gerlach E. The coronary endothelium: a highly effective barrier for adenosine. Basic Res Cardiol. 1985;80:515-529.
24. Kroll K, Schrader J, Piper HM, Henrich H. Release of adenosine and cyclic AMP from coronary endothelium in isolated guinea pig hearts: relation to coronary flow. Circ Res. 1987;60:659-665.
25. Forman MB, Velasoc CE, Jackson EK. Adenosine attenuates reperfusion injury following regional myocardial ischemia. Cardiovasc Res. 1993;27:9-17.
26. Nees S, Dendorfer A. New perspectives of myocardial adenine nucleotide metabolism. In: Imai S, Nakazawa M, eds. Role of Adenosine and Adenine Nucleotides in the Biological System. Amsterdam: Elsevier; 1991:273-288.
27. Asimakis GK, Inners-McBride K, Medellin G, Conti VR. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 1992;263:H887-H894.
28. Cohen MV, Downey JM. Ischaemic preconditioning: can the protection be bottled? Lancet. 1993;342:6.
29. ATP channels, and ischemic preconditioning in dogs. Am J Physiol. 1993;264:H1327-H1336.
30. 1-receptors. Circulation. 1992;86:1310-1316.
31. 1-adrenergic mechanism. Circ Res. 1993;73:656-670.
32. Toombs CF, Wiltse AL, Shebuski RJ. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium: implication of norepinephrine release in the preconditioning effect. Circulation. 1993;88:2351-2358.
33. Fralix TA, Steenbergen C, London RE, Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res. 1993; 27:630-637.
34. Cave AC, Collis CS, Downey JM, Hearse DJ. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res. 1993;27:663-668.
35. Li Y, Kloner RA. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. Circulation. 1993;87:1642-1648.
36. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther. 1993;265:559-564.
37. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol. 1990;259:H820-H826.
38. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
39. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate (5-HD). Cardiovasc Res. 1992;26:1054-1062.
40. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res. 1993;27:617-622.
41. Tan HL, Mazón P, Verberne HJ, Sleeswijk ME, Coronel R, Opthof T, Janse MJ. Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Cardiovasc Res. 1993;27:644-651.